HCV-related liver and lymphoproliferative diseases

Association with polymorphisms of IL28B and TLR2

Valli de Re, Mariangela de Zorzi, Laura Caggiari, Gianfranco Lauletta, Maria Lina Tornesello, Elisa Fognani, Marta Miorin, Vito Racanelli, Luca Quartuccio, Laura Gragnani, Sabino Russi, Fabio Pavone, Michela Ghersetti, Elena Garlatti Costa, Pietro Casarin, Riccardo Bomben, Cesare Mazzaro, Giancarlo Basaglia, Massimiliano Berretta, Emanuela Vaccher & 6 others Francesco Izzo, Franco Maria Buonaguro, Salvatore de Vita, Anna Linda Zignego, Paolo D. de Paoli, Riccardo Dolcetti

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

To explore the relationship between innate immunity and hepatitis C Virus (HCV) in determining the risk of cirrhosis (CIR), hepatocellular carcinoma (HCC), mixed cryoglobulinemia syndrome (MCS) and non-Hodgkin lymphoma (NHL), we investigated the impact of the toll-like receptor-2 (TLR2) and interleukin-28B (IL28B) genetic variants. TLR2 -174 del variant was associated with TLR2 expression and with specific downstream molecules that drive the expression of different interleukins; rs12979860 Il28B was important in response to interferon-treatment and in spontaneous clearance of HCV. The risk for liver and lymphoproliferative diseases in HCV progression was clarified by stratifying 862 HCV-positive patients into groups based on liver (CIR, HCC) and lymphoproliferative HCV-related diseases (MCS, NHL) and compared with chronic HCV (CHC) infection. Analysis of TLR2-IL28B haplotypes showed an association of wild type haplotype with the lymphoproliferative diseases (OR 1.77, p = 0.029) and a slight increase in HCV viral load (HR 1.38, p = 0.054). Wild type haplotype (TLR2 ins/ins- IL28B C/C) was also found associated with older age in patients with an hepatic diseases (in CIR and in HCC p = 0.038 and p = 0.020, respectively) supporting an effect of innate immunity in the liver disease progression. TLR2 and IL28B polymorphisms in combination showed a role in the control of HCV viral load and different HCV disease progression.

Original languageEnglish
Pages (from-to)37487-37497
Number of pages11
JournalOncotarget
Volume7
Issue number25
DOIs
Publication statusPublished - 2016

Fingerprint

Toll-Like Receptor 2
Interleukins
Hepacivirus
Liver Diseases
Virus Diseases
Haplotypes
Cryoglobulinemia
Hepatocellular Carcinoma
Viral Load
Innate Immunity
Non-Hodgkin's Lymphoma
Disease Progression
Gammaherpesvirinae
Fibrosis
Chronic Hepatitis C
Liver Cirrhosis
Interferons

Keywords

  • HCC
  • HCV
  • IL28B
  • Immune response
  • Immunity
  • Immunology and Microbiology Section
  • NHL
  • TLR2

ASJC Scopus subject areas

  • Oncology

Cite this

HCV-related liver and lymphoproliferative diseases : Association with polymorphisms of IL28B and TLR2. / de Re, Valli; de Zorzi, Mariangela; Caggiari, Laura; Lauletta, Gianfranco; Tornesello, Maria Lina; Fognani, Elisa; Miorin, Marta; Racanelli, Vito; Quartuccio, Luca; Gragnani, Laura; Russi, Sabino; Pavone, Fabio; Ghersetti, Michela; Costa, Elena Garlatti; Casarin, Pietro; Bomben, Riccardo; Mazzaro, Cesare; Basaglia, Giancarlo; Berretta, Massimiliano; Vaccher, Emanuela; Izzo, Francesco; Buonaguro, Franco Maria; de Vita, Salvatore; Zignego, Anna Linda; de Paoli, Paolo D.; Dolcetti, Riccardo.

In: Oncotarget, Vol. 7, No. 25, 2016, p. 37487-37497.

Research output: Contribution to journalArticle

de Re, V, de Zorzi, M, Caggiari, L, Lauletta, G, Tornesello, ML, Fognani, E, Miorin, M, Racanelli, V, Quartuccio, L, Gragnani, L, Russi, S, Pavone, F, Ghersetti, M, Costa, EG, Casarin, P, Bomben, R, Mazzaro, C, Basaglia, G, Berretta, M, Vaccher, E, Izzo, F, Buonaguro, FM, de Vita, S, Zignego, AL, de Paoli, PD & Dolcetti, R 2016, 'HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2', Oncotarget, vol. 7, no. 25, pp. 37487-37497. https://doi.org/10.18632/oncotarget.9303
de Re, Valli ; de Zorzi, Mariangela ; Caggiari, Laura ; Lauletta, Gianfranco ; Tornesello, Maria Lina ; Fognani, Elisa ; Miorin, Marta ; Racanelli, Vito ; Quartuccio, Luca ; Gragnani, Laura ; Russi, Sabino ; Pavone, Fabio ; Ghersetti, Michela ; Costa, Elena Garlatti ; Casarin, Pietro ; Bomben, Riccardo ; Mazzaro, Cesare ; Basaglia, Giancarlo ; Berretta, Massimiliano ; Vaccher, Emanuela ; Izzo, Francesco ; Buonaguro, Franco Maria ; de Vita, Salvatore ; Zignego, Anna Linda ; de Paoli, Paolo D. ; Dolcetti, Riccardo. / HCV-related liver and lymphoproliferative diseases : Association with polymorphisms of IL28B and TLR2. In: Oncotarget. 2016 ; Vol. 7, No. 25. pp. 37487-37497.
@article{ae036100226340c2a7bd649b75f9b572,
title = "HCV-related liver and lymphoproliferative diseases: Association with polymorphisms of IL28B and TLR2",
abstract = "To explore the relationship between innate immunity and hepatitis C Virus (HCV) in determining the risk of cirrhosis (CIR), hepatocellular carcinoma (HCC), mixed cryoglobulinemia syndrome (MCS) and non-Hodgkin lymphoma (NHL), we investigated the impact of the toll-like receptor-2 (TLR2) and interleukin-28B (IL28B) genetic variants. TLR2 -174 del variant was associated with TLR2 expression and with specific downstream molecules that drive the expression of different interleukins; rs12979860 Il28B was important in response to interferon-treatment and in spontaneous clearance of HCV. The risk for liver and lymphoproliferative diseases in HCV progression was clarified by stratifying 862 HCV-positive patients into groups based on liver (CIR, HCC) and lymphoproliferative HCV-related diseases (MCS, NHL) and compared with chronic HCV (CHC) infection. Analysis of TLR2-IL28B haplotypes showed an association of wild type haplotype with the lymphoproliferative diseases (OR 1.77, p = 0.029) and a slight increase in HCV viral load (HR 1.38, p = 0.054). Wild type haplotype (TLR2 ins/ins- IL28B C/C) was also found associated with older age in patients with an hepatic diseases (in CIR and in HCC p = 0.038 and p = 0.020, respectively) supporting an effect of innate immunity in the liver disease progression. TLR2 and IL28B polymorphisms in combination showed a role in the control of HCV viral load and different HCV disease progression.",
keywords = "HCC, HCV, IL28B, Immune response, Immunity, Immunology and Microbiology Section, NHL, TLR2",
author = "{de Re}, Valli and {de Zorzi}, Mariangela and Laura Caggiari and Gianfranco Lauletta and Tornesello, {Maria Lina} and Elisa Fognani and Marta Miorin and Vito Racanelli and Luca Quartuccio and Laura Gragnani and Sabino Russi and Fabio Pavone and Michela Ghersetti and Costa, {Elena Garlatti} and Pietro Casarin and Riccardo Bomben and Cesare Mazzaro and Giancarlo Basaglia and Massimiliano Berretta and Emanuela Vaccher and Francesco Izzo and Buonaguro, {Franco Maria} and {de Vita}, Salvatore and Zignego, {Anna Linda} and {de Paoli}, {Paolo D.} and Riccardo Dolcetti",
year = "2016",
doi = "10.18632/oncotarget.9303",
language = "English",
volume = "7",
pages = "37487--37497",
journal = "Oncotarget",
issn = "1949-2553",
publisher = "Impact Journals LLC",
number = "25",

}

TY - JOUR

T1 - HCV-related liver and lymphoproliferative diseases

T2 - Association with polymorphisms of IL28B and TLR2

AU - de Re, Valli

AU - de Zorzi, Mariangela

AU - Caggiari, Laura

AU - Lauletta, Gianfranco

AU - Tornesello, Maria Lina

AU - Fognani, Elisa

AU - Miorin, Marta

AU - Racanelli, Vito

AU - Quartuccio, Luca

AU - Gragnani, Laura

AU - Russi, Sabino

AU - Pavone, Fabio

AU - Ghersetti, Michela

AU - Costa, Elena Garlatti

AU - Casarin, Pietro

AU - Bomben, Riccardo

AU - Mazzaro, Cesare

AU - Basaglia, Giancarlo

AU - Berretta, Massimiliano

AU - Vaccher, Emanuela

AU - Izzo, Francesco

AU - Buonaguro, Franco Maria

AU - de Vita, Salvatore

AU - Zignego, Anna Linda

AU - de Paoli, Paolo D.

AU - Dolcetti, Riccardo

PY - 2016

Y1 - 2016

N2 - To explore the relationship between innate immunity and hepatitis C Virus (HCV) in determining the risk of cirrhosis (CIR), hepatocellular carcinoma (HCC), mixed cryoglobulinemia syndrome (MCS) and non-Hodgkin lymphoma (NHL), we investigated the impact of the toll-like receptor-2 (TLR2) and interleukin-28B (IL28B) genetic variants. TLR2 -174 del variant was associated with TLR2 expression and with specific downstream molecules that drive the expression of different interleukins; rs12979860 Il28B was important in response to interferon-treatment and in spontaneous clearance of HCV. The risk for liver and lymphoproliferative diseases in HCV progression was clarified by stratifying 862 HCV-positive patients into groups based on liver (CIR, HCC) and lymphoproliferative HCV-related diseases (MCS, NHL) and compared with chronic HCV (CHC) infection. Analysis of TLR2-IL28B haplotypes showed an association of wild type haplotype with the lymphoproliferative diseases (OR 1.77, p = 0.029) and a slight increase in HCV viral load (HR 1.38, p = 0.054). Wild type haplotype (TLR2 ins/ins- IL28B C/C) was also found associated with older age in patients with an hepatic diseases (in CIR and in HCC p = 0.038 and p = 0.020, respectively) supporting an effect of innate immunity in the liver disease progression. TLR2 and IL28B polymorphisms in combination showed a role in the control of HCV viral load and different HCV disease progression.

AB - To explore the relationship between innate immunity and hepatitis C Virus (HCV) in determining the risk of cirrhosis (CIR), hepatocellular carcinoma (HCC), mixed cryoglobulinemia syndrome (MCS) and non-Hodgkin lymphoma (NHL), we investigated the impact of the toll-like receptor-2 (TLR2) and interleukin-28B (IL28B) genetic variants. TLR2 -174 del variant was associated with TLR2 expression and with specific downstream molecules that drive the expression of different interleukins; rs12979860 Il28B was important in response to interferon-treatment and in spontaneous clearance of HCV. The risk for liver and lymphoproliferative diseases in HCV progression was clarified by stratifying 862 HCV-positive patients into groups based on liver (CIR, HCC) and lymphoproliferative HCV-related diseases (MCS, NHL) and compared with chronic HCV (CHC) infection. Analysis of TLR2-IL28B haplotypes showed an association of wild type haplotype with the lymphoproliferative diseases (OR 1.77, p = 0.029) and a slight increase in HCV viral load (HR 1.38, p = 0.054). Wild type haplotype (TLR2 ins/ins- IL28B C/C) was also found associated with older age in patients with an hepatic diseases (in CIR and in HCC p = 0.038 and p = 0.020, respectively) supporting an effect of innate immunity in the liver disease progression. TLR2 and IL28B polymorphisms in combination showed a role in the control of HCV viral load and different HCV disease progression.

KW - HCC

KW - HCV

KW - IL28B

KW - Immune response

KW - Immunity

KW - Immunology and Microbiology Section

KW - NHL

KW - TLR2

UR - http://www.scopus.com/inward/record.url?scp=84978045031&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978045031&partnerID=8YFLogxK

U2 - 10.18632/oncotarget.9303

DO - 10.18632/oncotarget.9303

M3 - Article

VL - 7

SP - 37487

EP - 37497

JO - Oncotarget

JF - Oncotarget

SN - 1949-2553

IS - 25

ER -